Passive Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$763K Sell
710
-20
-3% -$20.4K 0.24% 43
2026
Q1
$671K Buy
730
+20
+3% +$20.3K 0.2% 45
2025
Q4
$763K Buy
710
+8
+1% +$7.65K 0.24% 43
2025
Q3
$536K Sell
702
-11
-2% -$8.19K 0.17% 53
2025
Q2
$553K Hold
713
– – 0.17% 49
2025
Q1
$589K Sell
713
-5
-0.7% -$4.16K 0.19% 45
2024
Q4
$554K Hold
718
– – 0.2% 41
2024
Q3
$636K Hold
718
– – 0.22% 37
2024
Q2
$650K Buy
+718
New +$574K 0.24% 36
2022
Q3
– Sell
-648
Closed -$210K – 50
2022
Q2
$210K Buy
+648
New +$195K 0.11% 49

Other funds holding LLY

Passive Capital Management's LLY Position: Q2 2026 in Review

Passive Capital Management reduced its Eli Lilly (LLY) stake by 2.7% in Q2 2026, selling an estimated $20.4K and leaving 710 shares worth $763K. The position accounts for 0.24% of the portfolio, ranked #43.

Passive Capital Management first reported a position in LLY in Q2 2022 and has held it in 10 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Passive Capital Management held 710 shares of Eli Lilly worth $763K as of Q2 2026.
  • Passive Capital Management sold 20 Eli Lilly shares in Q2 2026, an estimated $20.4K.
  • Eli Lilly made up 0.24% of Passive Capital Management's portfolio in Q2 2026, its #43 holding.
  • Passive Capital Management first reported a position in Eli Lilly in Q2 2022 and has held it in 10 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Passive Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.